## PODD: Insulet Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.0% below STRENGTH zone (3.0-6.0%); PEG 2.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($271.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Insulet Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251224T170800 | Bullish | Relevance: 100%
- Insulet Corp. (PODD) stock rose 1.16% to $288.82 on Wednesday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a positive trading day. The stock closed 18.61% below its 52-week high of $354.88 achieved on November 20th.

**2. Swedbank AB Buys 5,000 Shares of Insulet Corporation $PODD**
- Source: MarketBeat | 20251227T104938 | Somewhat-Bullish | Relevance: 100%
- Swedbank AB increased its stake in Insulet Corporation by 6.9% in Q3, purchasing 5,000 shares to own 77,488 shares valued at approximately $23.9 million. Insulet (NASDAQ:PODD) holds a "Moderate Buy" consensus rating from analysts, with various price target adjustments from firms like JPMorgan and Truist. The company recently exceeded EPS expectations but fell short on revenue estimates in its latest earnings report.

**3. Osaic Holdings Inc. Purchases 5,309 Shares of Insulet Corporation $PODD**
- Source: MarketBeat | 20251227T101738 | Bullish | Relevance: 100%
- Osaic Holdings Inc. significantly increased its stake in Insulet Corporation by 152.9% in Q2, acquiring 5,309 additional shares to hold a total of 8,781 shares valued at approximately $2.709 million. Wall Street analysts maintain a "Moderate Buy" consensus rating for Insulet, with several firms recently raising their price targets. Insulet also reported Q1 EPS of $1.24, beating estimates, and revenue growth of 29.9% year-over-year.

**4. Beacon Investment Advisory Services Inc. Has $25.11 Million Stake in Insulet Corporation $PODD**
- Source: MarketBeat | 20251227T080838 | Somewhat-Bullish | Relevance: 100%
- Beacon Investment Advisory Services Inc. reduced its stake in Insulet Corporation (NASDAQ:PODD) by 8.2% in the third quarter, holding 81,340 shares valued at $25.11 million. Despite this reduction and a revenue miss, several other institutional investors increased their holdings, and Wall Street analysts generally maintain a "Moderate Buy" rating with an average price target of $379. Insulet recently reported strong Q1 earnings, beating EPS estimates, and its stock shows a market capitalization of $20.31 billion.

**5. Insulet Corporation $PODD Shares Acquired by Munro Partners**
- Source: MarketBeat | 20251224T121906 | Bullish | Relevance: 100%
- Munro Partners significantly increased its stake in Insulet Corporation (NASDAQ:PODD) during the third quarter, purchasing an additional 212,885 shares to hold a total of 227,240 shares valued at approximately $70.2 million. This move positions Insulet as Munro's 25th-largest holding, representing about 1.9% of its portfolio. Various other institutional investors also adjusted their holdings in Insulet, while analysts maintain a "Moderate Buy" rating with a consensus price target of $379.00 following Insulet's Q1 earnings beat.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Truist Securiti | $390 | $412 | -5% |
| 2025-12-17 | Canaccord Genui | $450 | $432 | +4% |
| 2025-12-16 | Evercore ISI Gr | $370 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Truist Securiti | main | Buy |
| 2025-12-17 | Canaccord Genui | main | Buy |
| 2025-12-16 | Evercore ISI Gr | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.80M) |
| Sells | 1 ($0.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+1.0%)
- FMR, LLC: 10.8% (+0.8%)
- Blackrock Inc.: 9.4% (+2.8%)
- Capital Research Glo: 6.5% (-4.0%)
- State Street Corpora: 4.4% (+1.1%)

### Key Risks

1. Premium valuation (P/E 47x, PEG 2.2x) vulnerable to multiple compression.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.15 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (2.9x). Revenue growth strong at 21% YoY. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.3B |
| Beta | 1.38 |
| 52W Range | $230.05 - $354.88 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.15 |
| Forward P/E | 46.7 |
| Current P/E | 59.0 |
| YoY Growth | 26.4% |
| EPS Direction | RISING |

### Technicals

MRS_10 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 5.0pp (needs >3.0% for momentum thesis). Below SMA200 (0.95x), long-term trend not supportive. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.00% (CS: 23) | Neutral |
| RSI_14 | 38.5 | Neutral |
| MACD Histogram | -0.21 | Bearish |
| vs SMA20 | 0.969x | Below |
| vs SMA50 | 0.919x | Below |
| vs SMA200 | 0.954x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $288.63
- **Stop Loss:** $271.11 (6.1% risk)
- **Target:** $306.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $21,647.25
- **Portfolio %:** 21.65%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-19 (Est: $1.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.15 | $1.24 | +8.1% |
| 2025Q2 | $0.92 | $1.17 | +26.8% |
| 2025Q1 | $0.79 | $1.02 | +29.7% |
| 2024Q4 | $1.02 | $1.15 | +12.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*